GlassScriptPhysician profile
Jaroslaw P Siwik
NPI 1043280522
$789.84
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $94.02 · 2022: $122 · 2023: $53.26 · 2024: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $99.19 | 2019-2020 | |
| Novo Nordisk INC | $96.66 | 2019-2022 | |
| Lilly USA, LLC | $76.04 | 2022-2024 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $65.33 | 2019-2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $57.11 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $44.31 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Novartis Pharmaceuticals Corporation | $41.99 | 2019-2023 | |
| Inspire Medical Systems, INC. | $41.10 | 2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $34.60 | 2022-2023 | |
| Shire North American Group INC | $30.55 | 2019 | |
| Pfizer INC. | $28.52 | 2019 | |
| Astellas Pharma US INC | $27.71 | 2019 | |
| Abbott Laboratories | $24.26 | 2022 | |
| Abbvie INC. | $22.40 | 2024 | |
| Phadia US INC. | $19.68 | 2023 | Immunocap |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.12 | 2024 | Jardiance |
| Radius Health, INC. | $17.81 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $17.44 | 2024 | Opsumit, Uptravi |
| Dexcom, INC. | $14.81 | 2024 | Dexcom G6 Transmitter |
| Circassia INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaroslaw Siwik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.